LFMD news

Latest 4 stories · newest Sep 15, 2026

LFMD

AT&T offers free LifeMD telehealth to millions of customers

LifeMD announced a partnership with AT&T to provide free virtual and pharmacy services to over 100 million eligible customers, marking a significant expansion of its U.S. subscriber base.

M&A Sep 15, 2026 sentiment 0.00 SEC filing ↗

LFMD

FDA Says It Has Received 990 Adverse Event Reports Tied To Compounded Semaglutide And More Than 730 Tied To Compounded Tirzepatide; Establishes Import Alert For Compounded GLP-1 Active Pharmaceutical Ingredients

Regulations Sep 1, 2026 sentiment 0.00 Source: benzinga.com ↗

LFMD

LifeMD Q2 2026 revenue within guidance of $47M-$50M

The company reported $47.3 million in revenue and a gross margin expansion to 89% as it transitions to branded GLP-1 therapies, while reiterating expectations for a return to positive adjusted EBITDA in the second half of 2026.

Earnings Aug 5, 2026 sentiment +0.75 SEC filing ↗

LFMD

LifeMD launches exclusive XYOSTED telehealth co-marketing program in July 2026

LifeMD announced an exclusive collaboration with Antares Pharma to offer a direct-to-patient self-pay program for XYOSTED testosterone injection, launching in 37 states at $249/month including care and medication. The partnership leverages LifeMD's virtual care platform and pharmacy to address fragm…

Other Jun 22, 2026 sentiment +0.75 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same LFMD feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/LFMD/newsSTART FREE